At BMed Global, we are an international community of professionals based in Latin America and Europe who believe in the transformative power of psychedelics to foster mental health and collective well-being. We are inspired by the idea that the next step in human evolution will not be individual, but collective: a network of awake and connected individuals, guided by empathy and respect for life.

Our mission is to weave this global community by exploring psychedelic-based therapeutic approaches that promote deep personal and social transformation. Together, we work towards a more conscious future, in harmony with nature and human potential.

We aspire to become a center of excellence in supporting the development and validation of transformative, psychedelic-based therapeutic approaches for mental health and well-being.

Synaptica Clinic, based in Barcelona, is dedicated to integrating psychedelic therapy into the field of mental health. Under the medical direction of Dr. Joan Obiols, the clinic offers treatments for conditions such as depression and anxiety through the clinical use of ketamine. This approach blends scientific research with ethical, personalized care to provide access to innovative therapeutic options.

Education and training are core pillars of Synaptica Clinic’s mission. Knowledge about the therapeutic potential of psychedelics is actively shared through partnerships—such as with the Ketamine Research Foundation—and through a trilingual blog that delivers accurate, accessible information.

Scientific research plays a central role at Synaptica. The clinic participates in clinical assessments and studies on ketamine for treatment-resistant disorders, contributing to the evolving field of psychedelic medicine. These efforts are reinforced through collaborations with national and international universities and institutions, and the clinic hosts students via academic agreements to help train the next generation of professionals in clinical and research settings.

Synaptica Clinic applies a holistic model of mental health, incorporating methods such as Holotropic Breathwork, TRE (Tension & Trauma Release Exercises), integrative medicine, medicinal cannabinoids, existential group psychotherapy, and psychoeducation. Continuous professional development is considered essential: specialized training and multidisciplinary collaboration among psychiatrists, psychologists, and therapists ensure high-quality, integrative care.

Myco-bag, based in Valencia, was born with a clear mission: to make the self-cultivation of psychoactive mushrooms simple, accessible, and safe, so that anyone can begin their journey into mycology without the need for major investments or prior technical knowledge.

Its flagship product is a sterilized, ready-to-use grow bag designed to simplify the entire cultivation process. Thanks to its practical format and high efficiency, Myco-bag enables both novice growers and experienced users to achieve consistent results. This ease of use has made the brand an ideal ally for those wishing to explore the world of mushrooms from home, with guarantees of quality and safety.

In collaboration with Full Canopy Genetics, a global leader in fungal genetic research based in Colorado (USA), Myco-bag ensures a high biological standard and rigorous genetic traceability. It also includes an exclusive added value: crop analysis through NIR spectroscopy thanks to technology developed by Valenveras, allowing users to determine the chemical profile of each harvest and adjust dosages precisely and personally.

Myco-bag’s vision goes beyond simple cultivation. It proposes a holistic model that integrates science, health, sustainability, and community empowerment. Each bag is an invitation to reconnect with nature, to cultivate consciously, and to actively participate in a global movement that recognizes the therapeutic, spiritual, and transformative value of mushrooms.

PSILOS is the first company in Europe to make psilocybin mushrooms widely available in three different formats.

At a crucial time when psychedelic-assisted therapies are gaining ground and science is validating the undeniable potential of these natural compounds for addressing mental health, PSILOS was born out of a deep conviction: that a future of greater well-being for all is possible. At PSILOS, there is a firm belief that these sacred molecules are an essential part of the rebirth of a unified and global consciousness.

This initiative is the result of a shared dream, born from a restless mind driven by the desire to face challenges that, although they may seem titanic, are the vital spark for its founder, Ángel Rodríguez Arnal.

PSILOS aims to be a spearhead in this movement, always willing to take on the risks and difficulties that come with being pioneers in any field. While the path may be demanding, PSILOS holds a strong belief that the human benefits generated by its activity far outweigh any potential concerns. On a journey that could well be described as a cosmic crusade for the common good, earthly obstacles and threats are not perceived as such.